Literature DB >> 26345874

Association of the VRK2 gene rs3732136 polymorphism with schizophrenia in a Northwest Chinese Han population.

B Zhang1, C Y Gao1, H B Zhang1, B Yang2, J F Yin3, S G Wei1, Y S Zhu1, X N Jia1, S B Li1.   

Abstract

Previous studies have found that the vaccinia related kinase 2 gene (VRK2) polymorphism was associated with schizophrenia (SCZ) in the worldwide population. This association was further supported by VRK2 mRNA expression patterns and brain structure variations. Here, we analyzed four single nucleotide polymorphisms (SNPs) of the VRK2 gene in a total population of 893 samples, consisting of 360 patients with SCZ and 533 healthy controls of Han Chinese descent using the SNPscan method. Single SNP, haplotype, and gender-specific association analyses were performed. We found that rs3732136 was significantly associated with SCZ (P = 0.042; odds ratio = 1.25; 95% confidence interval = 1.01-1.55). Further genotype and haplotype association analyses suggested a similar pattern. Our data provide preliminary evidence that the VRK2 gene might play a major role in the development of SCZ in the Northwest Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26345874     DOI: 10.4238/2015.August.14.4

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  3 in total

1.  Novel alternatively-spliced exons of the VRK2 gene in mouse brain and microglial cells.

Authors:  Salsabil Almarzooq; Jaedeok Kwon; Ashleigh Willis; John Craig; Brian J Morris
Journal:  Mol Biol Rep       Date:  2020-06-24       Impact factor: 2.316

2.  Glycogen synthase kinase 3β suppresses polyglutamine aggregation by inhibiting Vaccinia-related kinase 2 activity.

Authors:  Eunju Lee; Hye Guk Ryu; Sangjune Kim; Dohyun Lee; Young-Hun Jeong; Kyong-Tai Kim
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

3.  Identification and replication of RNA-Seq gene network modules associated with depression severity.

Authors:  Trang T Le; Jonathan Savitz; Hideo Suzuki; Masaya Misaki; T Kent Teague; Bill C White; Julie H Marino; Graham Wiley; Patrick M Gaffney; Wayne C Drevets; Brett A McKinney; Jerzy Bodurka
Journal:  Transl Psychiatry       Date:  2018-09-05       Impact factor: 6.222

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.